5% stakes
Venrock Healthcare Capital Partners III
Institution
- 5% stake reports
- 33
- 5% stake stocks
- 23
- Latest report
- 26/09/21
5% stake reports
| Stock | ||
|---|---|---|
| X4 Pharmaceuticals XFOR09/21 | 5.6%5,555,047 sh | First report |
| Korsana Biosciences KRSA09/15 | 9.9%4,552,277 sh | First report |
| Tenax Therapeutics TENX08/14 | 4.7%1,574,892 sh | −5.2pp |
| Oruka Therapeutics ORKA08/14 | 7.4%4,556,952 sh | −2.5pp |
| Jade Biosciences JBIO08/14 | 8.3%5,145,330 sh | −1.6pp |
| enGene Therapeutics ENGN08/14 | 0%0 sh | −7.1pp |
| Adlai Nortye Group ANL08/14 | 4.4%9,638,193 sh | −1.7pp |
| Relmada Therapeutics RLMD06/09 | 6.2%6,508,433 sh | First report |
| CytomX Therapeutics CTMX05/15 | 4.6%9,982,124 sh | −4.8pp |
| Enliven Therapeutics ELVN05/15 | 2.8%1,726,331 sh | −2.6pp |
| Oric Pharmaceuticals ORIC05/15 | 4.2%4,319,765 sh | −1.6pp |
| Achieve Life Sciences ACHV04/24 | 5.2%5,502,064 sh | First report |
| Korro Bio KRRO03/17 | 9.9%1,488,685 sh | First report |
| Damora Therapeutics DMRA02/17 | 6%3,603,595 sh | First report |
| Savara SVRA02/17 | 9.9%20,881,288 sh | +2.6pp |
| Oric Pharmaceuticals ORIC02/17 | 5.8%5,676,230 sh | −1.9pp |
| Ocular Therapeutix OCUL02/17 | 3.2%6,862,972 sh | −4.1pp |
| enGene Therapeutics ENGN02/17 | 7.1%4,771,414 sh | −2.8pp |
| Adlai Nortye Group ANL02/11 | 6.1%9,638,193 sh | First report |
| Century Therapeutics IPSC01/16 | 7.1%13,043,478 sh | +2.4pp |
